Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Shares Outstanding (Weighted Average): 2021-2024

Historic Shares Outstanding (Weighted Average) for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to $7.7 million.

  • Biofrontera's Shares Outstanding (Weighted Average) rose 92.45% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 92.45%. This contributed to the annual value of $7.7 million for FY2024, which is 410.61% up from last year.
  • As of FY2024, Biofrontera's Shares Outstanding (Weighted Average) stood at $7.7 million, which was up 410.61% from $1.5 million recorded in FY2023.
  • In the past 5 years, Biofrontera's Shares Outstanding (Weighted Average) ranged from a high of $7.7 million in FY2024 and a low of $752,800 during FY2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $3.5 million, with a median of $1.5 million in 2023.
  • Data for Biofrontera's Shares Outstanding (Weighted Average) shows a peak YoY soared of 410.61% (in 2024) over the last 5 years.
  • Yearly analysis of 4 years shows Biofrontera's Shares Outstanding (Weighted Average) stood at $752,800 in 2021, then skyrocketed by 77.33% to $1.3 million in 2022, then climbed by 13.68% to $1.5 million in 2023, then surged by 410.61% to $7.7 million in 2024.